VR Logo

Aurobindo Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 12 2021 for Axis Clinic Ltd Trident Chemphar Ltd & RPR Sons Advisors Pvt Ltd. (Jointly holding)

Click here to view PDF